SE464168B - Antiviral komposition bestaaende av en 3'-fluoro-2',3'-dideoxynukleosidfoerening och en 2',3'-dideoxynukleosidfoerening (exempelvis azt) - Google Patents
Antiviral komposition bestaaende av en 3'-fluoro-2',3'-dideoxynukleosidfoerening och en 2',3'-dideoxynukleosidfoerening (exempelvis azt)Info
- Publication number
- SE464168B SE464168B SE8902568A SE8902568A SE464168B SE 464168 B SE464168 B SE 464168B SE 8902568 A SE8902568 A SE 8902568A SE 8902568 A SE8902568 A SE 8902568A SE 464168 B SE464168 B SE 464168B
- Authority
- SE
- Sweden
- Prior art keywords
- compound
- azt
- fluoro
- flt
- composition according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8902568A SE464168B (sv) | 1989-07-19 | 1989-07-19 | Antiviral komposition bestaaende av en 3'-fluoro-2',3'-dideoxynukleosidfoerening och en 2',3'-dideoxynukleosidfoerening (exempelvis azt) |
ES90911382T ES2083458T3 (es) | 1989-07-19 | 1990-07-10 | Composicion antivirica. |
CA002063417A CA2063417C (en) | 1989-07-19 | 1990-07-10 | Antiviral composition |
AU60469/90A AU630220B2 (en) | 1989-07-19 | 1990-07-10 | Antiviral composition |
DE69024804T DE69024804T2 (de) | 1989-07-19 | 1990-07-10 | Antivirale zusammensetzung |
PCT/SE1990/000487 WO1991001137A1 (en) | 1989-07-19 | 1990-07-10 | Antiviral composition |
AT90911382T ATE132752T1 (de) | 1989-07-19 | 1990-07-10 | Antivirale zusammensetzung |
JP51055190A JP3149179B2 (ja) | 1989-07-19 | 1990-07-10 | 抗ウイルス組成物 |
DK90911382.1T DK0482081T3 (da) | 1989-07-19 | 1990-07-10 | Antiviralt præparat |
EP90911382A EP0482081B1 (de) | 1989-07-19 | 1990-07-10 | Antivirale zusammensetzung |
US08/354,891 US5571798A (en) | 1989-07-19 | 1994-12-09 | Synergistic antiviral nucleoside combinations |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8902568A SE464168B (sv) | 1989-07-19 | 1989-07-19 | Antiviral komposition bestaaende av en 3'-fluoro-2',3'-dideoxynukleosidfoerening och en 2',3'-dideoxynukleosidfoerening (exempelvis azt) |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8902568D0 SE8902568D0 (sv) | 1989-07-19 |
SE8902568L SE8902568L (sv) | 1991-01-20 |
SE464168B true SE464168B (sv) | 1991-03-18 |
Family
ID=20376569
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8902568A SE464168B (sv) | 1989-07-19 | 1989-07-19 | Antiviral komposition bestaaende av en 3'-fluoro-2',3'-dideoxynukleosidfoerening och en 2',3'-dideoxynukleosidfoerening (exempelvis azt) |
Country Status (11)
Country | Link |
---|---|
US (1) | US5571798A (de) |
EP (1) | EP0482081B1 (de) |
JP (1) | JP3149179B2 (de) |
AT (1) | ATE132752T1 (de) |
AU (1) | AU630220B2 (de) |
CA (1) | CA2063417C (de) |
DE (1) | DE69024804T2 (de) |
DK (1) | DK0482081T3 (de) |
ES (1) | ES2083458T3 (de) |
SE (1) | SE464168B (de) |
WO (1) | WO1991001137A1 (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2088443T3 (es) * | 1990-08-06 | 1996-08-16 | American Cyanamid Co | Procedimiento para la preparacion de desoxinucleosidos. |
EP0555302A1 (de) * | 1990-10-30 | 1993-08-18 | The Wellcome Foundation Limited | Verfahren zur behandlung von dimyelinierenden krankheiten |
IL100502A (en) * | 1991-01-03 | 1995-12-08 | Iaf Biochem Int | PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (- |
WO1992020344A1 (en) † | 1991-05-16 | 1992-11-26 | Glaxo Group Limited | Antiviral combinations containing nucleoside analogs |
GB9110874D0 (en) * | 1991-05-20 | 1991-07-10 | Iaf Biochem Int | Medicaments |
GB9226927D0 (en) * | 1992-12-24 | 1993-02-17 | Iaf Biochem Int | Dideoxy nucleoside analogues |
US5760013A (en) * | 1996-08-21 | 1998-06-02 | National Science Council | Thymidylate analogs and the use thereof |
US5841975A (en) * | 1996-12-10 | 1998-11-24 | The Regents Of The University Of California | Method and apparatus for globally-accessible automated testing |
US5968731A (en) * | 1996-12-10 | 1999-10-19 | The Regents Of The University Of California | Apparatus for automated testing of biological specimens |
US5925514A (en) * | 1996-12-10 | 1999-07-20 | The Regents Of The University Of California | Apparatus for testing for infection by a retrovirus |
DE19832519A1 (de) * | 1998-07-20 | 2000-01-27 | Hartmut Oswald | Arzneimittelzubereitungen zur topischen Behandlung mukokutaner Herpesinfektionen sowie der Keratitis herpetica des Auges |
US7534605B2 (en) * | 1999-06-08 | 2009-05-19 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases |
AU2003239088B2 (en) * | 2002-06-27 | 2006-11-02 | Medivir Ab | Synergistic interaction of abacavir and alovudine |
EP1610797A1 (de) * | 2003-03-27 | 2006-01-04 | Boehringer Ingelheim International GmbH | Antivirale kombination von nevirapin und einer weiteren antiretroviralen verbindung |
EP1610781A1 (de) | 2003-03-27 | 2006-01-04 | Boehringer Ingelheim International GmbH | Antivirale kombination von tipranavir und einer weiteren antiretroviralen verbindung |
WO2004087140A1 (en) * | 2003-03-27 | 2004-10-14 | Boehringer Ingelheim International Gmbh | Antiviral combination of a dipyridodiazepinone and a further antiretroviral compound |
EA200800932A1 (ru) * | 2005-09-26 | 2008-10-30 | Фармассет, Инк. | Модифицированные 4`-нуклеозиды в качестве противовирусных агентов |
GB0608876D0 (en) * | 2006-05-05 | 2006-06-14 | Medivir Ab | Combination therapy |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4724232A (en) * | 1985-03-16 | 1988-02-09 | Burroughs Wellcome Co. | Treatment of human viral infections |
WO1987001284A1 (en) * | 1985-08-26 | 1987-03-12 | United States Of America, Represented By The Unite | Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2',3'-dideoxynosine, 2',3'-dideoxyguanosine, or 2',3'-dideoxyadenosine |
US4879277A (en) * | 1985-08-26 | 1989-11-07 | The United States Of America As Represented By The Department Of Health And Human Services | Antiviral compositions and methods |
US4681933A (en) * | 1986-05-01 | 1987-07-21 | University Of Georgia Research Foundation, Inc. | 2',3'-dideoxy-5-substituted uridines and related compounds as antiviral agents |
US4916122A (en) * | 1987-01-28 | 1990-04-10 | University Of Georgia Research Foundation, Inc. | 3'-Azido-2',3'-dideoxyuridine anti-retroviral composition |
SE8602981D0 (sv) * | 1986-07-04 | 1986-07-04 | Astra Laekemedel Ab | Novel medicinal use |
US4880782A (en) * | 1986-11-21 | 1989-11-14 | Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften E.V. | Method of treating viral infections in humans and compositions therefor |
EP0286825A3 (de) * | 1987-03-18 | 1989-04-12 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Verwendung von 3'-fluro-3'-deoxythymidine zur Herstellung von medicamenten zur Behandlung von Viruskrankheiten |
US4908440A (en) * | 1987-11-12 | 1990-03-13 | Bristol Myers Company | 2',3'-dideoxy-2'-fluoroarabinopyrimidine nucleosides |
US4904770A (en) * | 1988-03-24 | 1990-02-27 | Bristol-Myers Company | Production of 2',3'-dideoxy-2',3'-didehydronucleosides |
US5122517A (en) * | 1988-06-10 | 1992-06-16 | Regents Of The University Of Minnesota | Antiviral combination comprising nucleoside analogs |
US5059418A (en) * | 1989-09-20 | 1991-10-22 | The Administrators Of The Tulane Educational Fund | Synergistic effect of human recombinant interferon-beta on halogenated pyrimidines |
US5026687A (en) * | 1990-01-03 | 1991-06-25 | The United States Of America As Represented By The Department Of Health And Human Services | Treatment of human retroviral infections with 2',3'-dideoxyinosine alone and in combination with other antiviral compounds |
GB9104740D0 (en) * | 1991-03-06 | 1991-04-17 | Wellcome Found | Antiviral nucleoside combination |
-
1989
- 1989-07-19 SE SE8902568A patent/SE464168B/sv not_active IP Right Cessation
-
1990
- 1990-07-10 DE DE69024804T patent/DE69024804T2/de not_active Expired - Lifetime
- 1990-07-10 ES ES90911382T patent/ES2083458T3/es not_active Expired - Lifetime
- 1990-07-10 CA CA002063417A patent/CA2063417C/en not_active Expired - Lifetime
- 1990-07-10 JP JP51055190A patent/JP3149179B2/ja not_active Expired - Fee Related
- 1990-07-10 DK DK90911382.1T patent/DK0482081T3/da active
- 1990-07-10 EP EP90911382A patent/EP0482081B1/de not_active Expired - Lifetime
- 1990-07-10 WO PCT/SE1990/000487 patent/WO1991001137A1/en active IP Right Grant
- 1990-07-10 AU AU60469/90A patent/AU630220B2/en not_active Expired
- 1990-07-10 AT AT90911382T patent/ATE132752T1/de not_active IP Right Cessation
-
1994
- 1994-12-09 US US08/354,891 patent/US5571798A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0482081B1 (de) | 1996-01-10 |
JPH04506961A (ja) | 1992-12-03 |
EP0482081A1 (de) | 1992-04-29 |
ATE132752T1 (de) | 1996-01-15 |
ES2083458T3 (es) | 1996-04-16 |
AU6046990A (en) | 1991-02-22 |
AU630220B2 (en) | 1992-10-22 |
SE8902568L (sv) | 1991-01-20 |
SE8902568D0 (sv) | 1989-07-19 |
US5571798A (en) | 1996-11-05 |
JP3149179B2 (ja) | 2001-03-26 |
DE69024804T2 (de) | 1996-08-29 |
CA2063417C (en) | 2000-12-12 |
DE69024804D1 (de) | 1996-02-22 |
WO1991001137A1 (en) | 1991-02-07 |
CA2063417A1 (en) | 1991-01-20 |
DK0482081T3 (da) | 1996-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE464168B (sv) | Antiviral komposition bestaaende av en 3'-fluoro-2',3'-dideoxynukleosidfoerening och en 2',3'-dideoxynukleosidfoerening (exempelvis azt) | |
Balzarini et al. | 9-(2-Phosphonylmethoxyethyl) adenine (PMEA) effectively inhibits retrovirus replication in vitro and simian immunodeficiency virus infection in rhesus monkeys | |
KR100454663B1 (ko) | 프로테아제억제제에기초한요법에서세포내프로테아제억제제의흡수를증가시키기위한제약조성물 | |
Gustafson et al. | AIDS-antiviral sulfolipids from cyanobacteria (blue-green algae) | |
Fauci et al. | The acquired immunodeficiency syndrome: an update | |
Tsai et al. | Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl) adenine | |
US8158575B2 (en) | Agent for the prevention and treatment of sexually transmitted diseases-I | |
Koshida et al. | Structure-activity relationships of fluorinated nucleoside analogs and their synergistic effect in combination with phosphonoformate against human immunodeficiency virus type 1 | |
Connolly et al. | Antiretroviral therapy: reverse transcriptase inhibition | |
Busso et al. | Nucleotide dimers suppress HIV expression in vitro | |
CA1339854C (en) | Viral treatment system | |
US5084445A (en) | 3'-azido-2',3'-dideoxy-5-methylcytidine | |
Kong et al. | Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2', 3'-dideoxythymidine | |
Baba et al. | Selective inhibition of human immunodeficiency virus type 1 replication by novel fluoroalkylated oligomers in vitro | |
Zeidner et al. | Zidovudine in combination with alpha interferon and interleukin-2 as prophylactic therapy for FeLV-induced immunodeficiency syndrome (FeLV-FAIDS) | |
De Simone et al. | Clinical and immunological assessment in HIV+ subjects receiving inosine-pranobex. A randomised, multicentric study | |
SK168196A3 (en) | Anti-hiv triple combination | |
AU7959291A (en) | Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome | |
WO2002059123A2 (en) | Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds | |
CA2498934C (en) | Compositions for inducing increased levels of .beta.-chemokines and methods of use therefor | |
Nakashima et al. | Sulfated alkyl oligosaccharides inhibit human immunodeficiency virus in vitro and provide sustained drug levels in mammals | |
US20040110774A1 (en) | Methods and formulations of using A1 adenosine receptor antagonists and P2x purinoceptor antagonists for the treatment and prevention of immune system disorders | |
US20020182151A1 (en) | Benzoylalkylindolepyridinium componds and pharmaceutical compositions comprising such compounds | |
Broom et al. | Unusual single-stranded polyribonucleotides as potent anti-HIV agents | |
BHAT et al. | Benzopurpurin and related compounds inhibit the binding of gp120 to galactosyl ceramide/sulfatide and infection of human immunodeficiency virus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 8902568-8 Format of ref document f/p: F |
|
NUG | Patent has lapsed |